Home India Ministry of Commerce and Industry Amendment in export Policy of Human Biological Samples under...
Date: 2024-03-11 Category: Not Applicable State: Union Government Country: India

Amendment in export Policy of Human Biological Samples under Chapter-30 of ITC HS schedule-2 of export policy.

Issued by Ministry of Commerce and Industry · Directorate General Of Foreign Trade

Research with AI Agent Chat with Document Generate Summary Translate Helpful Share Add to Project Create Task

Executive Summary & Key Takeaways

**Summary:** This notification, issued by the Directorate General of Foreign Trade, Ministry of Commerce and Industry, Government of India, effective March 1, 2024, amends the export policy for Human Biological Samples under Chapter 30 of the ITC (HS) schedule 2 of export policy. Specifically, Notification No. 22023 revises the export policy for items falling under HS codes 30021020, 30021091, 30021210, 30021220, 30021230, 30021240, 30021290 and 30029010. The amended policy now permits the free export of human biological materials/samples/products under Chapter 30, subject to obtaining a No Objection Certificate (NOC) from either the Central Drugs Standard Control Organization (CDSCO) or the Indian Council of Medical Research (ICMR), Department of Health Research (DHR). For items under the aforementioned HS codes related to activities covered under the provision of Drugs and Cosmetics Act 1940 Rules thereunder, export is free subject to NOC from CDSCO. Items NOT covered are free for export subject to NOC from IEMRDHR. This change is enacted under the authority of Section 3 and 5 of the Foreign Trade (Development and Regulation) Act, 1992, and paragraphs 1.02 and 2.01 of the Foreign Trade Policy, 2023. For further information, contact the Director General of Foreign Trade at dgft@nic.in, referencing file number F. No. 01/91/180/148/AM23/EC/e-35188.

Key Entities Referenced

Directorate General of Foreign Trade: The issuing authority of the notification, responsible for foreign trade regulation. Foreign Trade Development Regulation Act, 1992: The primary legislation authorizing the government to regulate foreign trade. Foreign Trade Policy, 2023: The prevailing foreign trade policy document that guides export/import regulations. Human Biological Samples: The subject of the export policy amendment, specifically related to Chapter 30 of the ITC HS schedule 2. ITC HS schedule2: Indian Trade Classification based on Harmonized System of Coding. This schedule defines the export policy. Central Drugs Standard Control Organization: An organization from which a No Objection Certificate (NOC) is required for the export of certain human biological samples. Indian Council of Medical Research: An organization, operating under Department of Health Research, from which a No Objection Certificate (NOC) is required for the export of certain human biological samples. Drugs Cosmetics Act 1940: The legislation governing drugs and cosmetics, relevant to the export of human biological samples related to activities covered under its provisions.
Official Source Record View Original Source →
See Full Document Text
[To be Published in the Gazette of India Extraordinary Part-II, Section - 3, Sub-Section (ii)] Ministry of Commerce & Industry Department of Commerce Directorate General of Foreign Trade Vanijya Bhawan, New Delhi Notification No. {2/2023 New Delhi, Dated: 1(**March, 2024 Subject: Amendment in export Policy of Human Biological Samples under Chapter-30 of ITC HS schedule-2 of export policy. S.0. (E). — In exercise of powers conferred by Section 3 read with section 5 of the Foreign Trade (Development & Regulation) Act, 1992 (No. 22 of 1992), as amended, read with Para 1.02 and 2.01 of the Foreign Trade Policy, 2023, the Central Government hereby amends Export Policy under chapter 30 related to Human Biological Samples, as under: IHS Code [Item Description Revised |Revised Policy Condition |Export 30021020 | Antisera and other blood |P Fo rl ei ec y 1. Any human biological fractions and immunological |subject to materials/samples/products which products, whether or not [NOC are related to activities covered modified or obtained by means under the provision of Drugs & of biotechnological processes Cosmetics Act 1940 & Rules 30021091 | Antisera and other blood thereunder are free for export fractions and immunological subject to No objection from products, whether or not CDSCO. m ofo d bi if oi te ed ch nor o lo ob gt ica ai ln e pd r ob cy e sm se ea s ns 2. Any human biological 30021210 | For diphtheria materials/samples/products NOT 50021220 | For tetanus covered under (1) above are free 0021230 | For rabies for export subject to No objection 50021240 _| For snake venom from IEMRDHR: 30021290 _| Other 30029010 | Human Blood 2. Effect of the Notification: Export Policy of Human Biological Samples under Chapter 30 of ITC HS schedule-2 of export policy is amended to the extent that export of item that contains Human biological materials/samples/products under chapter 30 is free subject to the NOC from Central Drugs Standard Control Organization (CDSCO) or Indian Council of Medical Research (ICMR), Department of Health Research (DHR). a . aA (Santosh ‘Kumar Sarangi) Director General of Foreign Trade Ex-Officio Additional Secretary, Government of India E-mail: dgft@nic.in (Issued from F. No. 01/91/191/48/AM23/EC/e-35 188)

Continue your research